ArticleOncotarget2018

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models.

Oi Kwan Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.